ADAG
Adagene Inc
NASDAQ: ADAG · HEALTHCARE · BIOTECHNOLOGY
$3.55
+0.57% today
Updated 2026-04-29
Market cap
$234.56M
P/E ratio
—
P/S ratio
30.58x
EPS (TTM)
$-0.37
Dividend yield
—
52W range
$1 – $5
Volume
0.3M
Adagene Inc (ADAG) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
| Total assets | $54.42M | $105.89M | $84.26M | $189.51M | $152.40M | $115.73M | $89.27M |
| Cash & equivalents | $16.06M | $92.53M | $75.15M | $174.39M | $143.76M | $109.93M | $85.19M |
| Current assets | $51.82M | $103.92M | $79.10M | $185.95M | $149.32M | $113.44M | $87.78M |
| Total liabilities | $95.44M | $162.90M | $173.65M | $32.95M | $69.31M | $45.17M | $38.74M |
| Current liabilities | $10.35M | $7.18M | $16.15M | $29.82M | $55.08M | $31.46M | $38.18M |
| Long-term debt | — | $1.52M | $2.97M | $2.99M | $14.15M | $13.54M | $417339.00 |
| Shareholder equity | $-41.03M | $-57.01M | $-89.39M | $156.56M | $83.09M | $70.56M | $50.52M |
| Retained earnings | $-46.83M | $-63.26M | $-105.66M | $-178.83M | $-258.81M | $-277.75M | $-311.18M |
| Accounts receivable | $1.43M | $2.14M | $132396.00 | $7.51M | $619432.00 | $222027.00 | $8309.00 |
| Inventory | — | $1.00 | — | $1.00 | — | — | — |
| Goodwill | — | — | — | — | — | — | — |